Rankings
▼
Calendar
CPRX Q3 2017 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
CPRX
Catalyst Pharmaceuticals, Inc.
$3B
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$3M
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-0.05
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$529,738
Balance Sheet
Total Assets
$35M
Total Liabilities
$3M
Stockholders' Equity
$32M
Cash & Equivalents
$7M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$3M
-$2M
-8.5%
Operating Income
-$4M
-$4M
-10.0%
Net Income
-$4M
-$4M
-5.7%
← FY 2017
All Quarters
Q4 2017 →